ASX:VTI Visioneering Technologies (VTI) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free VTI Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Visioneering Technologies alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Visioneering TechnologiesVisioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.Read More Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide VTI Stock News HeadlinesMarch 1, 2024 | nz.finance.yahoo.comAla. Mom Who Was Tortured, Sexually Assaulted and Fatally Shot Remembered for 'Heart of Gold'March 1, 2024 | finance.yahoo.comVisioneering Technologies Full Year 2023 Earnings: US$0.099 loss per share (vs US$0.23 loss in FY 2022)April 26, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.January 18, 2024 | msn.comASX Health Stocks: Mesoblast rockets 20pc after being granted Rare Pediatric Disease Designation by FDADecember 19, 2023 | seekingalpha.comBullish Sentiment Is Too High Going Into Recession: Sell VTI (Rating Downgrade)November 5, 2023 | msn.comMarket Chart Storm: VTI Poised For Gains Into Year End, Soft Landing In PlayOctober 13, 2023 | msn.comVTI: What's Different From SPY And How We Use ItOctober 11, 2023 | msn.comMarket Highlights: ASX set to rise again, Birkenstock’s disappointing IPO, and 5 ASX small caps to watch todayApril 26, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.September 15, 2023 | msn.comVTI ETF: This Diversified Powerhouse Owns Over 3,800 StocksSeptember 2, 2023 | finance.yahoo.comVTI.AX - Visioneering Technologies, Inc.August 30, 2023 | finance.yahoo.comVTI Appoints Dr. Juan Carlos Aragón as CEO and Executive DirectorMay 25, 2023 | finance.yahoo.comSeveral Insiders Invested In Visioneering Technologies Flagging Positive NewsMay 25, 2023 | finance.yahoo.comSeveral Insiders Invested In Visioneering Technologies Flagging Positive News \May 14, 2023 | forbes.comWingtech TechnologyApril 2, 2023 | morningstar.comVisioneering Technologies Inc Shs Chess Depository Interests Repr 1 Sh VTI Stock QuoteMarch 4, 2023 | finance.yahoo.comVisioneering Technologies Full Year 2022 Earnings: US$0.19 loss per share (vs US$0.11 loss in FY 2021)March 1, 2023 | seekingalpha.comSCHD Vs. VTI: Which ETF Is The Better Buy?February 20, 2023 | marketwatch.comOrthokeratology Lens Market By Suppliers, Type, Application and Sales Price, Forecast 2023-2028January 28, 2023 | msn.comUnlock the Secrets of Investing: VTSAX vs VTI Showdown - Which One Reigns Supreme?December 7, 2022 | seekingalpha.comVTI: Monetary Policy Miscalculation Remains A Risk For 2023November 25, 2022 | finance.yahoo.comA Visioneering Technologies, Inc. (ASX:VTI) insider increased their holdings by 44% last yearSeptember 28, 2022 | reuters.comVisioneering Technologies IncSeptember 19, 2022 | nasdaq.comVTI, KO, COST, ACN: Large Inflows Detected at ETFAugust 16, 2022 | finance.yahoo.comLoss-Making Visioneering Technologies, Inc. (ASX:VTI) Expected To Breakeven In The Medium-TermJuly 24, 2022 | seekingalpha.comVTI: How 'Brand Value' Stocks Make And Beat Broad BenchmarksJuly 13, 2022 | seekingalpha.comVTI: Risk/Reward Appears Reasonable AgainSee More Headlines Receive VTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Visioneering Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:VTI CUSIPN/A CIKN/A Webwww.vtivision.com Phone844-884-5367FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,450,000.00 Net Margins-39.80% Pretax MarginN/A Return on Equity-57.27% Return on Assets-29.77% Debt Debt-to-Equity Ratio3.70 Current Ratio4.08 Quick Ratio4.82 Sales & Book Value Annual Sales$8.67 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.11 per share Price / BookN/AMiscellaneous Outstanding Shares55,430,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.68 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Brian D. Lane CPA (Age 62)Chief Operating & Chief Financial Officer Comp: $451.21kDr. Kuang-Mon Tuan FAAOPh.D., Chief Medical OfficerDr. Juan Carlos AragonCEO & Executive DirectorDr. Richard A. GriffinFounder & Medical AdviserMs. Layna L. MendlingerGlobal Head of MarketingMs. Leanne Ralph AAICDACIS, BBus, Company SecretaryMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersJuan AragonSold 425,000 sharesTotal: $95,625.00 ($0.23/share) This page (ASX:VTI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Visioneering Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
